Clinical Trials on Hyperphosphatemia in United States
Total 102 results
-
Fresenius Medical Care Deutschland GmbHSiro Clinpharm Germany GmbHCompletedESRD | HyperphosphataemiaUnited Kingdom, Spain, Denmark, Germany
-
Washington University School of MedicineCompletedHyperphosphatemiaUnited States
-
Fresenius Medical Care North AmericaRenal Research InstituteCompleted
-
University of Illinois at ChicagoShireCompletedHyperphosphatemia in Chronic Kidney DiseaseUnited States
-
NYU Langone HealthCompletedHyperphosphatemia | Cardiovascular Disease (CKD)United States
-
Kaiser PermanenteKeryx BiopharmaceuticalsCompletedHyperphosphatemiaUnited States
-
Fresenius Medical Care North AmericaCompletedHyperphosphatemiaUnited States
-
ArdelyxCompletedHyperphosphatemiaUnited States
-
Daiichi Sankyo, Inc.CompletedHyperphosphatemiaUnited States
-
ShireCompletedHyperphosphatemiaUnited States, Germany, United Kingdom
-
Laura TosiChildren's National Research Institute; Ultragenyx Pharmaceutical IncActive, not recruitingCutaneous Skeletal Hypophosphatemia Syndrome (CSHS) | Epidermal Nevus SyndromeUnited States
-
Washington University School of MedicineCompletedHyperphosphatemiaUnited States
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-Linked HypophosphatemiaUnited States
-
Montefiore Medical CenterTerminatedRenal Transplant | HypophosphatemiaUnited States
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-Linked HypophosphatemiaKorea, Republic of, Canada, United States, Australia, Japan, United Kingdom, Sweden
-
Vifor Fresenius Medical Care Renal PharmaCompletedHyperphosphatemiaSpain, Netherlands, Germany, Italy, France, Greece, United Kingdom
-
ArdelyxCompletedHyperphosphatemiaUnited States, Poland, United Kingdom, Slovakia
-
Kyowa Kirin, Inc.CompletedX-Linked HypophosphatemiaUnited States
-
Novartis PharmaceuticalsCompletedHyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement TherapyGermany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
-
Kyowa Kirin Pharmaceutical Development LtdRecruitingX-Linked HypophosphatemiaFrance, Netherlands, United Kingdom
-
Kyowa Hakko Kirin Pharma, Inc.Completed
-
Yale UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedHypophosphatemic Rickets, X Linked DominantUnited States
-
ArdelyxCompletedHyperphosphatemiaUnited States
-
University of Colorado, DenverCompletedHyperphosphatemia | Hypoalbuminemia | Peritoneal Dialysis ComplicationUnited States
-
Chugai PharmaceuticalCompletedHyperphosphatemiaUnited States
-
Denver Nephrologists, P.C.CM&D Pharma LimitedCompletedChronic Kidney Disease | HyperphosphatemiaUnited States
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaNetherlands, United States, United Kingdom, France
-
University of Illinois at ChicagoShireCompletedHyperphosphatemia | Kidney DiseaseUnited States
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Vifor Fresenius Medical Care Renal PharmaTerminatedHyperphosphatemiaUnited States, Poland, Germany, Lithuania, France, Romania, Russian Federation
-
Fresenius Medical Care North AmericaCompleted
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Korea, Republic of, Japan, Ireland, United Kingdom, France, Italy
-
ArdelyxCompletedHyperphosphatemia | Chronic Kidney Disease Requiring Chronic DialysisUnited States
-
Yale UniversityCompleted
-
Keryx BiopharmaceuticalsRecruitingHyperphosphatemia Related to Chronic Kidney DiseaseUnited States
-
Kyowa Kirin Pharmaceutical Development LtdActive, not recruitingX-Linked HypophosphatemiaSpain, Italy, United Kingdom, France, Belgium, Denmark, Germany, Hungary, Portugal, Norway, Switzerland, Israel, Netherlands, Czechia, Bulgaria, Sweden, Slovenia, Ireland, Latvia, Slovakia
-
Indiana UniversityCompletedChronic Kidney DiseaseUnited States
-
Denver Nephrologists, P.C.CM&D Pharma LimitedCompletedChronic Kidney Disease | HyperphosphatemiaUnited States
-
Massachusetts General HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingX-linked Hypophosphatemia | Hypophosphatemic Rickets | Hypophosphatemic Rickets, X-Linked DominantUnited States
-
IlypsaUnknownKidney Diseases | Renal InsufficiencyUnited States
-
Kyowa Kirin Pharmaceutical Development LtdCompletedX-linked HypophosphatemiaUnited Kingdom, France, Ireland, Italy
-
Medialis Ltd.Metabolic Support UKCompletedX-linked Hypophosphatemia (XLH)United Kingdom
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
ArdelyxCompletedEnd Stage Renal Disease | HyperphosphatemiaUnited States
-
Wake Forest University Health SciencesCompletedHypophosphatemia | X-linked Hypophosphatemia | Left Ventricular Hypertrophy | Renin-angiotensin SystemUnited States
-
Nabi BiopharmaceuticalsCompletedKidney Failure | HyperphosphatemiaUnited States
-
Kyowa Kirin Pharmaceutical Development LtdActive, not recruitingX-linked Hypophosphatemia (XLH)Sweden, Spain, United Kingdom, Italy, Austria, France
-
NephrianUnknownInflammation | Hyperphosphatemia | Renal DiseaseUnited States
-
Winthrop University HospitalKeryx BiopharmaceuticalsTerminatedEnd Stage Renal Disease | Chronic Inflammation | HyperphosphatemiaUnited States
-
Children's Mercy Hospital Kansas CityWithdrawn